Sivik Global Healthcare’s Celgene Corp CELG Stock Holding History

Sivik Global Healthcare’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50,000	Closed	-$4.96M	–	57
2019 Q3	$4.96M	Sell	50,000 -10,000	-17%	-$950K	2.51%	23
2019 Q2	$5.55M	Hold	60,000	–	–	1.34%	18
2019 Q1	$5.66M	Buy	+60,000	New	+$5.25M	2.09%	20
2018 Q4	–	Sell	-50,000	Closed	-$4.47M	–	67
2018 Q3	$4.47M	Buy	50,000 +20,000	+67%	+$1.77M	1.6%	29
2018 Q2	$2.38M	Buy	+30,000	New	+$2.49M	0.92%	45
2018 Q1	–	Sell	-50,000	Closed	-$5.22M	–	78
2017 Q4	$5.22M	Sell	50,000 -5,000	-9%	-$564K	1.94%	19
2017 Q3	$8.02M	Sell	55,000 -5,000	-8%	-$681K	2.73%	7
2017 Q2	$7.79M	Buy	60,000 +12,500	+26%	+$1.53M	2.85%	5
2017 Q1	$5.91M	Sell	47,500 -20,000	-30%	-$2.39M	2.75%	10
2016 Q4	$7.81M	Sell	67,500 -5,000	-7%	-$557K	3.73%	3
2016 Q3	$7.58M	Buy	72,500 +17,500	+32%	+$1.89M	3.82%	4
2016 Q2	$5.42M	Buy	55,000 +15,000	+38%	+$1.55M	2.7%	8
2016 Q1	$4M	Hold	40,000	–	–	1.77%	24
2015 Q4	$4.79M	Sell	40,000 -10,000	-20%	-$1.16M	2.27%	16
2015 Q3	$5.41M	Buy	50,000 +10,300	+26%	+$1.28M	2.62%	11
2015 Q2	$4.59M	Sell	39,700 -10,300	-21%	-$1.18M	1.59%	24
2015 Q1	$5.76M	Sell	50,000 -16,299	-25%	-$1.95M	1.96%	14
2014 Q4	$7.42M	Buy	66,299 +31,299	+89%	+$3.3M	3%	4
2014 Q3	$3.32M	Buy	35,000 +20,000	+133%	+$1.8M	1.51%	31
2014 Q2	$2.58M	Sell	15,000 -24,160	-62%	-$1.84M	1.3%	36
2014 Q1	$2.73M	Sell	39,160 -840	-2%	-$66.5K	1.71%	24
2013 Q4	$3.38M	Buy	+40,000	New	+$3.17M	2.4%	12

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Sivik Global Healthcare's CELG Position: Q4 2019 in Review

Sivik Global Healthcare sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 50,000 shares — an estimated $4.96M sold.

Sivik Global Healthcare first reported a position in CELG in Q4 2013 and held it in 22 quarters. The position peaked at $8.02M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Sivik Global Healthcare reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Sivik Global Healthcare sold 50,000 Celgene Corp shares in Q4 2019, an estimated $4.96M.
Sivik Global Healthcare first reported a position in Celgene Corp in Q4 2013 and held it in 22 quarters.
Sivik Global Healthcare's Celgene Corp position peaked at $8.02M in Q3 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Sivik Global Healthcare's 13F filing for Q4 2019, filed 13 Feb 2020.